Section
Health
Public health, medicine and healthcare policy. Study findings are traced to the registered trial or the published paper itself, and drug and device actions to the federal recall record.
NIH Study Links Brown Fat to Lower Anxiety
An NIH-funded study linked higher brown fat activity to lower anxiety and depression in over 100,000 patients. The research also found the drug losartan boosts brown fat activity in mice.
Latest in Health
UK Sugar Rationing Linked to Lower Diabetes Risk
A study finds early exposure to UK sugar rationing lowers type 2 diabetes risk by 35%. Researchers attribute this protection to physiological changes from limited sugar intake in the first 1,000 days.
Sterling Recalls 750,000 Eye Products for Sterility
Sterling Pharmaceutical Services recalled nearly 750,000 eye-care products on Aug. 20 due to sterility concerns. The FDA classified the action as Class II, warning that use could cause temporary health issues.
Kenya Confirms First Imported Ebola Case From Congo
Kenyan authorities confirmed the nation's first imported Ebola case from Congo on October 6, 2026. The patient died at Nairobi Hospital while twenty-eight contacts enter isolation.
Kenya Confirms First Ebola Death, Traces 28 Contacts
Kenya confirmed its first Ebola death on October 6 and began tracing 28 contacts of the patient. The deceased man traveled from the Democratic Republic of Congo, prompting officials to seek 27 others from his flight.
CMS Awards $10 Billion to States for Rural Health
The Centers for Medicare & Medicaid Services awarded $10 billion in initial funding to all 50 states in late 2025. This allocation represents a 53% increase in federal support compared to 2024 Medicaid spending on rural hospitals.
Hochul Declares Emergency to Expand Measles Vaccines in New York
Governor Kathy Hochul declared a state disaster emergency on October 5, 2026, to expand measles vaccine administration in New York.
Frutas y Hortalizas Expands Berry Recall for E. Coli
Frutas y Hortalizas del Sur S.A. expanded its frozen berry recall on October 2 due to potential E. coli contamination. The action covers Great Value and Trader Joe's products distributed across 30 states and Puerto Rico.
PepsiCo Recalls 122,021 Gatorade Cases for Undeclared Dyes
PepsiCo recalled 122,021 cases of Gatorade in September 2024 due to undeclared Yellow No. 5 and Yellow No. 6 dyes. The Class II recall affects products distributed across 37 states and carries a risk of allergic reactions.
FDA Seeks Input on Ibogaine Trial Design
The FDA requested information on designing early-phase clinical trials for ibogaine drug products. The agency seeks comments, data, and information on dose selection and safety monitoring with comments due November 20, 2026.
GAO Report Finds Lower Payments at Owned Pharmacies
The GAO reported on October 5, 2026, that owned pharmacies received lower payments for most common drugs. In 2023, these pharmacies saw cost sharing up to $340 higher for some high-payment medications.
FDA Classifies U.S. Hereditary Cancer DNA Test as Class II
The FDA classified a hereditary cancer DNA test system as Class II with special controls on October 5, 2026. This action mandates accuracy thresholds of at least 99.0 percent to ensure reliable clinical results.
Shipilova Dies as Russia Monitors Irkutsk Contacts
Darya Shipilova died October 2 in Irkutsk after Rospotrebnadzor diagnosed pneumonia of unknown etiology. Nearly 200 contacts remain under medical observation while officials dispute plague involvement.
EBO-PEP Trial Enrolls 250 for Ebola Drug Test in Congo
The EBO-PEP trial has enrolled more than 250 participants in Congo to test obeldesivir for preventing Ebola infection.
FDA Ends Taylor Farms Cyclospora Probe After Mexico Findings
The FDA closed its cyclospora investigation into Taylor Farms after finding the parasite at a Mexican facility. The outbreak caused 12,883 illnesses and two deaths across 21 states before ending last month.
EASD Meeting Finds GLP-1 Drugs Work Better for Women
Researchers at the 2026 EASD Annual Meeting reported that GLP-1 receptor agonists produce greater weight loss in women than men. The study found 66.5% of women achieved at least 5% weight loss compared to 58.0% of men.
Medical Groups Issue 2026 Vaccine Guidelines
Medical groups issued independent 2026 vaccine guidelines after the CDC failed to update advice. These recommendations cover flu, COVID-19, and RSV shots for children and adults.
US Teens Face Late Colorectal Cancer Diagnosis in Study
A study finds 80% of US teens with colorectal cancer had late-stage disease. Researchers report 45.2% of the 84 patients died while incidence rates rise sharply. The median age of patients was 16.5 years old and about 37% experienced a recurrence.
JAMA Study: Lean MASLD Patients Face High Risks
A JAMA study finds lean MASLD patients face mortality risks similar to overweight counterparts. Fibrosis severity drives outcomes more than body mass index across 41 countries.
Survodutide Trial Shows Weight Loss, High Discontinuation Rates
The SYNCHRONIZE-2 trial found survodutide improved metabolic parameters but caused high discontinuation rates due to side effects.
Edinburgh, Birmingham Launch £7.9M Bipolar Diet Trial
Universities of Edinburgh and Birmingham launched the £7.9 million ENERGISE-BD trial to test ketogenic diets for bipolar disorder.
San Diego State Football Team Reports 14 Mumps Cases
San Diego County officials confirmed 14 mumps cases within the San Diego State football team as of Wednesday.
Boston Children's Hospital IDs FAH as Breast Cancer Drug Resistance Driver
Researchers identified FAH as a driver of resistance to CDK4/6 inhibitors in breast cancer. The finding suggests nuclear FAH could serve as a biomarker for treatment failure.
Alliance A071801 Trial Finds Survival Gain
The Alliance A071801 trial found fractionated radiosurgery improved median survival to 29 months versus 20 months for single-fraction treatment.